HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Experiments with a reported anorexigenic tripeptide: pyro-Glu-His-Gly-OH.

Abstract
A newly described tripeptide, pyro-Glu-His-Gly-OH, which was reported to produce profound and long-term anorexia and weight loss in female mice, was initially tested in female rats. After total dose of either 8, 16, or 32 microgram SC of the peptide, administered across an eight day interval, there was no detectable effect on food intake, body weight, or estrous cycles of female rats. In a second study, we attempted to verify the anorexigenic potency of this peptide in mice. Total doses of 3.4 and 6.8 microgram, injected across a 20 day period, had no effect on the food intake or body weight of S/W albino female mice. Thus, the anorexigenic potency of pyro-Glu-His-Gly-OH has yet to be established.
AuthorsD M Nance, D H Coy, A J Kastin
JournalPharmacology, biochemistry, and behavior (Pharmacol Biochem Behav) Vol. 11 Issue 6 Pg. 733-5 (Dec 1979) ISSN: 0091-3057 [Print] United States
PMID538064 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Appetite Depressants
  • Oligopeptides
  • pyroglutamyl-histidyl-glycine
  • Pyrrolidonecarboxylic Acid
Topics
  • Animals
  • Appetite Depressants
  • Body Weight (drug effects)
  • Eating (drug effects)
  • Female
  • Mice
  • Oligopeptides (pharmacology)
  • Pyrrolidonecarboxylic Acid (analogs & derivatives)
  • Rats
  • Species Specificity
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: